Status:
COMPLETED
KIDSTAGE- Staging of Kidney Cancer Using Dual Time PET/CT and Other Biomarkers
Lead Sponsor:
Odense University Hospital
Conditions:
Carcinoma, Renal Cell
Eligibility:
All Genders
18+ years
Brief Summary
Kidney cancer is a highly malignant disease with 950 new cases every year in Denmark. Diagnosis and treatment of kidney cancer patients presents many challenges because that early stages of the diseas...
Detailed Description
Background Renal cell carcinoma (RCC) represents 2-3% of all malignancies, and the European prevalence is approximately 84,400 cases per year \[1\]. In Denmark 950 new cases of Kidney Cancer (KC) are ...
Eligibility Criteria
Inclusion
- KC patients at Urological- and Oncological departments of OUH
- Written consent
- Able to speak and understand Danish
Exclusion
- Patients below 18 years of age
- Patients with mental impairment
- Withdrawal of consent
- Other malignancy
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04295174
Start Date
January 1 2018
End Date
January 1 2020
Last Update
March 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital
Odense C, Odense, Denmark, 5000